May 14, 2026
Gene
Researchers have developed a gene-based blood test that may help identify early signs of melanoma recurrence. This non-invasive test uses genetic markers to detect cancer cells in the bloodstream, potentially improving outcomes for patients with this aggressive form of skin cancer.